Evidence map›Paper›PMID 32894170›Full record

ArticleJournal of neuroinflammation2020

Alterations of peripheral nerve excitability in an experimental autoimmune encephalomyelitis mouse model for multiple sclerosis.

Nathalia Bernardes Teixeira, Gisele Picolo, Aline Carolina Giardini, Fawzi Boumezbeur, Géraldine Pottier, Bertrand Kuhnast, Denis Servent, Evelyne Benoit

Open access · goldAbstract read
In one paragraph

Article in Journal of neuroinflammation, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Glial cells and neurologic autoimmune disorders.Frontiers in cellular neuroscience · 2022
    Review
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Nathalia Bernardes TeixeiraUniversité Paris-Saclay, CEA, Département Médicaments et Technologies pour la Santé (DMTS), Service d'Ingénierie Moléculaire pour la Santé (SIMoS), ERL CNRS 9004, Gif-sur-Yvette, France.
Gisele PicoloLaboratory of Pain and Signaling, Butantan Institute, São Paulo, Brazil.
Aline Carolina GiardiniLaboratory of Pain and Signaling, Butantan Institute, São Paulo, Brazil.
Fawzi BoumezbeurUniversité Paris-Saclay, CEA, NeuroSpin, Gif-sur-Yvette, France.
Géraldine PottierUniversité Paris-Saclay, CEA, Inserm, BioMaps, Orsay, France.
Bertrand KuhnastUniversité Paris-Saclay, CEA, Inserm, BioMaps, Orsay, France.
Denis ServentUniversité Paris-Saclay, CEA, Département Médicaments et Technologies pour la Santé (DMTS), Service d'Ingénierie Moléculaire pour la Santé (SIMoS), ERL CNRS 9004, Gif-sur-Yvette, France.
Evelyne BenoitUniversité Paris-Saclay, CEA, Département Médicaments et Technologies pour la Santé (DMTS), Service d'Ingénierie Moléculaire pour la Santé (SIMoS), ERL CNRS 9004, Gif-sur-Yvette, France. evelyne.benoit@cea.fr.ORCID http://orcid.org/0000-0001-5501-0888
Centre National de la Recherche Scientifique · FRInserm · FRInstituto Butantan · BRCommissariat à l'Énergie Atomique et aux Énergies Alternatives · FR

Funding

CAPES 001Center of Toxins, Immune Response and Cell Signaling 2013/07467-1São Paulo Research Foundation 2011/17974-2
6 · The paper itself

Abstract

backgroundExperimental autoimmune encephalomyelitis (EAE) is the most commonly used and clinically relevant murine model for human multiple sclerosis (MS), a demyelinating autoimmune disease characterized by mononuclear cell infiltration into the central nervous system (CNS). The aim of the present study was to appraise the alterations, poorly documented in the literature, which may occur at the peripheral nervous system (PNS) level.

methodsTo this purpose, a multiple evaluation of peripheral nerve excitability was undertaken, by means of a minimally invasive electrophysiological method, in EAE mice immunized with the myelin oligodendrocyte glycoprotein (MOG) 35-55 peptide, an experimental model for MS that reproduces, in animals, the anatomical and behavioral alterations observed in humans with MS, including CNS inflammation, demyelination of neurons, and motor abnormalities. Additionally, the myelin sheath thickness of mouse sciatic nerves was evaluated using transmission electronic microscopy.

resultsAs expected, the mean clinical score of mice, daily determined to describe the symptoms associated to the EAE progression, increased within about 18 days after immunization for EAE mice while it remained null for all control animals. The multiple evaluation of peripheral nerve excitability, performed in vivo 2 and 4 weeks after immunization, reveals that the main modifications of EAE mice, compared to control animals, are a decrease of the maximal compound action potential (CAP) amplitude and of the stimulation intensity necessary to generate a CAP with a 50% maximum amplitude. In addition, and in contrast to control mice, at least 2 CAPs were recorded following a single stimulation in EAE animals, reflecting various populations of sensory and motor nerve fibers having different CAP conduction speeds, as expected if a demyelinating process occurred in the PNS of these animals. In contrast, single CAPs were always recorded from the sensory and motor nerve fibers of control mice having more homogeneous CAP conduction speeds. Finally, the myelin sheath thickness of sciatic nerves of EAE mice was decreased 4 weeks after immunization when compared to control animals.

conclusionsIn conclusion, the loss of immunological self-tolerance to MOG in EAE mice or in MS patients may not be only attributed to the restricted expression of this antigen in the immunologically privileged environment of the CNS but also of the PNS.

Indexed as

Action PotentialsAnimalsDisease ProgressionEncephalomyelitis, Autoimmune, ExperimentalMiceMuscle, SkeletalMyelin-Oligodendrocyte GlycoproteinMyelin SheathNeural ConductionPeptide FragmentsPeripheral NervesMyelin-Oligodendrocyte Glycoproteinmyelin oligodendrocyte glycoprotein (35-55)Peptide FragmentsElectrophysiologyExperimental autoimmune encephalomyelitisMouseMultiple sclerosisMyelin oligodendrocyte glycoproteinNeuromuscular junctionPeripheral nervous system

Identifiers

PMID32894170
PMCPMC7487851
OpenAlexW3083781109

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.